Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125963591 | 12596359 | 1 | I | 20160423 | 20160714 | 20160726 | 20160726 | EXP | GB-TEVA-677629ACC | TEVA | 78.00 | YR | F | Y | 0.00000 | 20160726 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125963591 | 12596359 | 1 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 1000 MILLIGRAM DAILY; 500 MG, BID | U | U | 75975 | 500 | MG | TABLET | BID | |||||
| 125963591 | 12596359 | 2 | I | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | 10 MILLIGRAM DAILY; 10 MG, 1D | U | U | 0 | 10 | MG | TABLET | QD | |||||
| 125963591 | 12596359 | 3 | I | MALARONE | ATOVAQUONEPROGUANIL HYDROCHLORIDE | 1 | UNK | U | 0 | TABLET | |||||||||
| 125963591 | 12596359 | 4 | C | ADCAL-D3 | CALCIUM CARBONATECHOLECALCIFEROL | 1 | UNK | 0 | CHEWABLE TABLET | ||||||||||
| 125963591 | 12596359 | 5 | C | AMLODIPINE | AMLODIPINE BESYLATE | 1 | 5 MILLIGRAM DAILY; 5 MG, 1D | 0 | 5 | MG | CAPSULE | QD | |||||||
| 125963591 | 12596359 | 6 | C | ATORVASTATIN | ATORVASTATIN | 1 | 20 MILLIGRAM DAILY; 20 MG, 1D | 0 | 20 | MG | QD | ||||||||
| 125963591 | 12596359 | 7 | C | GAVISCON | ALUMINUM HYDROXIDEMAGNESIUM CARBONATE | 1 | UNK | 0 | |||||||||||
| 125963591 | 12596359 | 8 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | 20 MILLIGRAM DAILY; 20 MG, 1D | 0 | 20 | MG | CAPSULE | QD | |||||||
| 125963591 | 12596359 | 9 | C | TRAMADOL. | TRAMADOL | 1 | 25 MILLIGRAM DAILY; 50 MG, QOD | 0 | 50 | MG | CAPSULE | QOD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125963591 | 12596359 | 1 | Product used for unknown indication |
| 125963591 | 12596359 | 2 | Arthritis |
| 125963591 | 12596359 | 3 | Prophylaxis |
| 125963591 | 12596359 | 4 | Product used for unknown indication |
| 125963591 | 12596359 | 5 | Product used for unknown indication |
| 125963591 | 12596359 | 6 | Product used for unknown indication |
| 125963591 | 12596359 | 7 | Product used for unknown indication |
| 125963591 | 12596359 | 8 | Product used for unknown indication |
| 125963591 | 12596359 | 9 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125963591 | 12596359 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125963591 | 12596359 | Aggression | |
| 125963591 | 12596359 | Circulatory collapse | |
| 125963591 | 12596359 | Contusion | |
| 125963591 | 12596359 | Drug interaction | |
| 125963591 | 12596359 | Eye contusion | |
| 125963591 | 12596359 | Fall | |
| 125963591 | 12596359 | Injury | |
| 125963591 | 12596359 | Memory impairment | |
| 125963591 | 12596359 | Vomiting |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125963591 | 12596359 | 3 | 20160423 | 20160423 | 0 |